The Effect of Dehydroepiandrosterone Supplementation to Symptomatic Perimenopausal Women on Serum Endocrine Profiles, Lipid Parameters, and Health-Related Quality of Life
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Circulating levels of dehydroepiandrosterone (DHEA), an androgen primarily of adrenal gland origin, decline with advancing age so that perimenopausal women have only about half of peak levels. Although scientific data are limited, DHEA has been increasingly used as a dietary supplement to combat symptoms of aging and to enhance general well-being. This is the first randomized, double-blind, placebo-controlled study of oral DHEA supplementation. Sixty perimenopausal women aged 45 to 55 years who reported symptoms of fatigue, anxiety, irritability, depression, insomnia, difficulty remembering or concentrating, or decreased libido and who had been amenorrheic for at least 2 months in the past year but not for longer than 12 months formed the study population. They were assigned to receive 50 mg of DHEA daily in capsule form or a placebo capsule for 3 months. The treatment and placebo groups were comparable at baseline. Serum testosterone as well as DHEA levels rose significantly in the treated group, and cortisol levels declined significantly compared with the placebo group. High-density lipoprotein levels fell 10 percent from baseline in women assigned to receive DHEA and 3 percent in placebo recipients. Lipoprotein(a) levels decreased 18 and 8 percent, respectively. There were no significant changes in total cholesterol, triglycerides, low-density lipoprotein, or apolipoprotein levels. Scores for change in the severity of perimenopausal symptoms did not differ significantly in the treatment and control groups after 3 months. Overall, there was a significant reduction in total symptom scores and improvement in quality-of-life scores. These findings suggest that DHEA supplementation would best be used under medical supervision and that endocrine and lipid parameters should be monitored in recipients. There is no support for replacing estrogen by DHEA when treating perimenopausal or postmenopausal symptoms. There is insufficient evidence to warrant prescribing DHEA to improve well-being and quality of life. J Clin Endocrinol Metab 1999;84:3896–3902
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ORENTREICH, N., BRIND, J. L., RIZER, R. L., & VOGELMAN, J. H. (1984) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-59-3-551 · Cited by 1,349
Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age.
Morales, A. J., Nolan, J. J., Nelson, J. C., & Yen, S. S. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.78.6.7515387 · Cited by 841 · cited 2×
“The only placebo-controlled human study of DHEA replacement assessing well-being noted 82% of the treated women (n 5 17) reporting an improvement in well-being compared with less than 10% of those who received placebo ( 1 ).”
BackgroundMorales, A. J., Haubrich, R. H., Hwang, J. Y., Asakura, H., & Yen, S. S. C. (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00507.x · Cited by 418
Physiological importance of dehydroepiandrosterone.
Eberling, P., & Koivisto, V. A. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92587-9 · Cited by 365 · cited 1×
“DHEA is also an androgen precursor and, therefore, could have a similar effect on a woman’s lipid profile (21, 34 ).”
BackgroundThe effects of oral dehydroepiandrosterone on endocrine-metabolic parameters in postmenopausal women
MORTOLA, J. F., & YEN, S. S. C. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-71-3-696 · Cited by 311
Dehydroepiandrosterone and its sulfate enhance memory retention in mice.
Flood, J. F., Smith, G. E., & Roberts, E. (1988) · Brain Research · doi:10.1016/0006-8993(88)91129-8 · Cited by 227
Psychometric performance during withdrawal from long-term benzodiazepine treatment
Petursson, H., Gudjonsson, G. H., & Lader, M. H. (1983) · Psychopharmacology · doi:10.1007/bf00427575 · Cited by 62
Cited by
Nelson, H. D. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60346-3 · Cited by 729
Labrie, F., Luu-The, V., Labrie, C., Bélanger, A., Simard, J., Lin, S.-X., & Pelletier, G. (2003) · Endocrine Reviews · doi:10.1210/er.2001-0031 · Cited by 544
Testosterone and Depression: Systematic Review and Meta-Analysis
Zarrouf, F. A., Artz, S., Griffith, J., Sirbu, C., & Kommor, M. (2009) · Journal of Psychiatric Practice · doi:10.1097/01.pra.0000358315.88931.fc · Cited by 383
Dehydroepiandrosterone Monotherapy in Midlife-Onset Major and Minor Depression
Schmidt, P. J., Daly, R. C., Bloch, M., Smith, M. J., Danaceau, M. A., Simpson St. Clair, L., Murphy, J. H., Haq, N., & Rubinow, D. R. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.2.154 · Cited by 254
Elraiyah, T., Sonbol, M. B., Wang, Z., Khairalseed, T., Asi, N., Undavalli, C., Nabhan, M., Altayar, O., Prokop, L., Montori, V. M., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2261 · Cited by 97
“Barnhart, 1999 (27) United States, academic hospital 66 Perimenopausal women”
Background
Metadata
- Authors
- Barnhart, K. T., Freeman, E., Grisso, J. A., Rader, D. J., Sammel, M., Kapoor, S., & Nestler, J. E.
- Venue
- Obstetrical & Gynecological Survey
- Published
- 2000-04
- Volume
- 55
- Issue
- 4
- Pages
- 225-226
- ISSN
- 0029-7828 (ISSN-L)
- OpenAlex
- W1965260099
- Cited by
- 62
- References
- 7
- FWCI
- 1.89
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Effect of Dehydroepiandrosterone Supplementation to Symptomatic Perimenopausal Women on Serum Endocrine Profiles, Lipid Parameters, and Health-Related Quality of Life. https://app.cochat.ai/papers/10.1097/00006254-200004000-00020
- The paper
- Barnhart, K. T., Freeman, E., Grisso, J. A., Rader, D. J., Sammel, M., Kapoor, S., & Nestler, J. E. (2000). The Effect of Dehydroepiandrosterone Supplementation to Symptomatic Perimenopausal Women on Serum Endocrine Profiles, Lipid Parameters, and Health-Related Quality of Life. Obstetrical & Gynecological Survey. https://doi.org/10.1097/00006254-200004000-00020
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.